IVETTE VALDES: Open Payments
NPI 1982087466 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,242 in 41 payments from 16 companies in 2025. Trend: 2023 $1,098 · 2024 $1,190 · 2025 $1,242
Food & beverage: $1,242
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 13 | $254 |
| Medtronic, Inc. | 1 | $173 |
| SCPHARMACEUTICALS INC. | 3 | $169 |
| Boston Scientific Corporation | 1 | $143 |
| Esperion Therapeutics, Inc. | 5 | $109 |
| Merck Sharp & Dohme LLC | 4 | $85 |
| Alnylam Pharmaceuticals Inc. | 3 | $66 |
| Novartis Pharmaceuticals Corporation | 3 | $59 |
| Neuros Medical, Inc. | 1 | $35 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $32 |
Products named: CAMZYOS, ONYX FRONTIER, FUROSCIX, General - Vascular Intervention, NEXLETOL, AMVUTTRA, VERQUVO, LEQVIO.
Industry payments across FL — which companies pay providers there.
